Standard Nuclear Strikes Long Term TRISO Nuclear Fuel Deal With Radiant Industries
Standard Nuclear (NYSE: STDN) has entered into a new binding fuel supply agreement with nuclear microreactor startup Radiant Industries.
Standard Nuclear (NYSE: STDN) has entered into a new binding fuel supply agreement with nuclear microreactor startup Radiant Industries.
BTC Digital Ltd. drives cryptocurrency innovation with mining, infrastructure, and asset management solutions, aiming to transform the blockchain landscape.
Alta Global Group drives innovation in martial arts and combat sports, enhancing consumer engagement through technology, programs, and strategic partnerships.
CBAK Energy Technology (Nasdaq: CBAT) develops high-power lithium-ion and sodium-ion batteries for electric vehicles and energy storage systems worldwide.
authID develops a cloud-based biometric identity platform for digital onboarding, authentication, passwordless access and fraud prevention across enterprise applications.
PharmAla Biotech is a Canadian company specializing in the research, development, and manufacturing of clinical-grade MDMA and novel MDXX compounds.
Focus Graphite Inc. develops high-purity flake graphite in Québec for EV batteries, nuclear tech, and clean energy markets across North America.
Micron (NASDAQ: MU) has unveiled Micron Research Labs to advance memory and compute breakthroughs for artificial intelligence.
Ur-Energy (NYSE: URG) has successfully made their first shipment of uranium from their Shirley Basin mine in Wyoming to their Lost Creek processing plant.
Conexeu Sciences (NASDAQ: CNXU) has publicly stated they are aiming to position their CXU platform for medical aesthetics and tissue restoration.
Stripe has entered into a deal to acquire artificial intelligence model routing platform OpenRouter.
Marvell Technology (NASDAQ: MRVL) and Google (NASDAQ: GOOG) have expanded their existing deal for custom silicon for Google’s TPU ecosystem.
Moderna (NASDAQ: MRNA) and Merck (NYSE: MRK) have publicly stated they've achieved a positive Phase III readout for their personalized cancer vaccine.
The markets and trends that matter, made simple.



Join top talent at the world's most respected institutions, companies, and venture capital funds.